Meridian Growth Fund® Class C MRCGX

Morningstar Medalist Rating
  • NAV / 1-Day Return$24.59  /  −0.77%
  • Fund Size$418.4M
  • Adjusted Expense Ratio2.010%
  • Net Expense Ratio1.960%
  • Fee Level: DistributionBelow Average
  • Share Class TypeLevel Load
  • Morningstar CategorySmall Growth
  • Equity Style Box (Funds)Small Growth
  • Minimum Initial Investment$2,500
  • Investment StatusLimited
  • TTM Yield0.00%
  • Turnover Ratio49%

Morningstar’s Analysis MRCGX

Will MRCGX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

Meridian Growth C holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings MRCGX

  • Current Portfolio Date
  • Equity Holdings—
  • Bond Holdings—
  • Other Holdings—
  • % Assets in Top 10 Holdings20.7
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Veracyte Inc

2.2810M
Healthcare

Hinge Health Inc Ordinary Shares - Class A

2.2710M
Healthcare

Trimble Inc

2.1310M
Technology

Axogen Inc

2.089M
Healthcare

Curtiss-Wright Corp

2.059M
Industrials

Dynatrace Inc Ordinary Shares

2.059M
Technology

Federal Signal Corp

2.019M
Industrials

Kirby Corp

1.989M
Industrials

RB Global Inc

1.969M
Industrials

Definium Therapeutics Inc Ordinary Shares

1.919M
Healthcare

Sponsor Center